Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Patients affected by multiple myeloma undergone autologous stem cell transplantation (SCT) are enrolled at the moment of stem cell collection. They are randomized 1:1 in two groups at the moment of the graft. Patients of the Control group take only standard antimicrobial prophylaxis after SCT; the Sample group takes in addition a daily oral supplementation of Zinc Sulfate (600 mg/die) from day +5 until day +100 after SCT. Laboratory tests are performed on peripheral blood samples.
Epistemonikos ID: 69b46e4bb544b8e0fe3fb185a969b8fb2e3e94f6
First added on: May 20, 2024